Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.6701
-0.0489 (-6.80%)
At close: Jun 12, 2026, 4:00 PM EDT
0.6650
-0.0051 (-0.76%)
After-hours: Jun 12, 2026, 7:31 PM EDT
Enlivex Market Cap
Enlivex has a market cap or net worth of $161.53 million as of June 12, 2026. Its market cap has increased by 622.34% in one year.
Market Cap
161.53M
Enterprise Value
156.41M
1-Year Change
622.34%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has increased from $101.63M to $161.53M, an increase of 58.93%. That is a compound annual growth rate of 6.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 161.53M | -3.23% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 169.87M |
| Innate Pharma | 169.69M |
| OnKure Therapeutics | 169.66M |
| Protalix BioTherapeutics | 168.39M |
| Korro Bio | 167.45M |
| Spero Therapeutics | 165.02M |
| Kazia Therapeutics | 163.18M |
| Oramed Pharmaceuticals | 158.38M |